Filter results

Pharmaceutical Industry Reports

By Geography
By Sector
By Publication Type
Showing
1-20 of 113
Algeria Pharmaceuticals & Healthcare Report

Algeria Pharmaceuticals & Healthcare Report

BMI View: Sustained development of Algeria's pharmaceutical and healthcare sector will remain a government priority over the coming years, despite economic deceleration. The ongoing expansion and modernisation of healthcare infrastructure will support the growing ...
$1,345.00
Read More
Angola Pharmaceuticals & Healthcare Report

Angola Pharmaceuticals & Healthcare Report

BMI View: The economic crisis in Angola has been devastating for the country's fragile healthcare system, which saw frequent shortages of many essential medicines in 2016 and fuelled the rise of deadly outbreaks of malaria ...
$1,345.00
Read More
Argentina Pharmaceuticals & Healthcare Report

Argentina Pharmaceuticals & Healthcare Report

BMI View: Argentina will remain one of Latin America's most attractive markets to multinational pharmaceutical firms over the forecast period. This is supported by the relatively high spending per capita on medicine, as well ...
$1,345.00
Read More
Asia Pharmaceuticals & Healthcare Report

Asia Pharmaceuticals & Healthcare Report

BMI View : Acts undertaken by US President Donald Trump will shape the Asia Pacific's pharmaceutical sectors. The withdrawal of the US from the Trans-Pacific Partnership is particularly significant, passing up an opportunity to introduce ...
$1,345.00
Read More
Australia Pharmaceuticals & Healthcare Report

Australia Pharmaceuticals & Healthcare Report

BMI View: The listing of high-value pharmaceuticals on the Australian Pharmaceutical Benefit Scheme will remain challenging. While additional funding allocations to the scheme can be expected, these will be subject to negotiations, with authorities leveraging ...
$1,345.00
Read More
Austria Pharmaceuticals & Healthcare Report

Austria Pharmaceuticals & Healthcare Report

BMI View: Austria's skilled workforce and location at the heart of Europe would make it ideal as a manufacturing hub, but the country has largely been surpassed by neighbouring Germany and Switzerland in terms ...
$1,345.00
Read More
Bahrain Pharmaceuticals & Healthcare Report

Bahrain Pharmaceuticals & Healthcare Report

BMI View: Opportunities in Bahrain's pharmaceutical market will continue to be outweighed by an unfavourable risk profile. Opportunities exist for manufacturers willing to invest in a small yet risky market, yet the dominance of ...
$1,345.00
Read More
Bangladesh Pharmaceuticals & Healthcare Report

Bangladesh Pharmaceuticals & Healthcare Report

BMI View: Opportunities for pharmaceutical firms in Bangladesh will remain limited for high-value medicines. Healthcare access in the country remains low and affordability remains a significant constraint given the high levels of out-of-pocket health expenditure. ...
$1,345.00
Read More
Belarus Pharmaceuticals & Healthcare Report

Belarus Pharmaceuticals & Healthcare Report

BMI View: Investment within Belarus' domestic pharmaceutical industry will continue at pace. Numerous industry-specific risks, such as bias in the medicine tendering process and pricing controls, as well as the weakness of the ruble will ...
$1,345.00
Read More
Belgium Pharmaceuticals & Healthcare Report

Belgium Pharmaceuticals & Healthcare Report

BMI View : Belgium offers a stable pharmaceutical market with high per capita spending on medicines. However, h eightened political uncertainty and a regional economic downturn will overshadow Belgium's economic outlook for the foreseeable future. ...
$1,345.00
Read More
Botswana Pharmaceuticals & Healthcare Report

Botswana Pharmaceuticals & Healthcare Report

BMI View : The government's commitment to improving healthcare in Botswana will gradually increase patient access to medicines and treatments. We expect that this , along with a rising communicable-disease burden , will drive pharmaceutical consumption, with ...
$1,345.00
Read More
Brazil Pharmaceuticals & Healthcare Report

Brazil Pharmaceuticals & Healthcare Report

BMI View: The Brazilian pharmaceutical market will stimulate greater interest from foreign multinationals in the coming years. The weakening of the Brazilian real, government efforts to promote the local pharmaceutical industry and greater international collaboration ...
$1,345.00
Read More
Bulgaria Pharmaceuticals & Healthcare Report

Bulgaria Pharmaceuticals & Healthcare Report

BMI View: There is an increasing need for the effective use of funds within the Bulgarian healthcare system which in itself is in a dire state and requires significant reform. This focus on greater spending ...
$1,345.00
Read More
Cambodia Pharmaceuticals & Healthcare Report

Cambodia Pharmaceuticals & Healthcare Report

BMI View: Cambodia's gradual expansion of health coverage will translate in to rising demand for medical treatment over a multi-year horizon. As the health system continues to develop, the rapidly ageing population will underpin ...
$1,345.00
Read More
Cameroon Pharmaceuticals & Healthcare Report

Cameroon Pharmaceuticals & Healthcare Report

BMI View: Rising private consumption on the back of positive developments in other areas of the economy bodes well for Cameroon's pharmaceutical market growth over the next two years. Moreover, recent government efforts to ...
$1,345.00
Read More
Canada Pharmaceuticals & Healthcare Report

Canada Pharmaceuticals & Healthcare Report

BMI View: Canada's strong publicly funded healthcare system and stable political environment make for an attractive base for sales and manufacturing. We forecast steady market growth - pricing and reimbursement pressures represent the main ...
$1,345.00
Read More
Chile Pharmaceuticals & Healthcare Report

Chile Pharmaceuticals & Healthcare Report

BMI View: Chile's economic and political outlook is promising despite setbacks originating in the copper sector. A resilient labour market and investment outside of the mining sector will support the Chilean economy in the ...
$1,345.00
Read More
China Pharmaceuticals & Healthcare Report

China Pharmaceuticals & Healthcare Report

BMI View: Challenges facing multinational pharmaceutical firms in China will continue into 2017. Reflecting the ongoing evolution of the healthcare market, key trends in 2016 - such as the ban on public hospital drug mark-ups, pressure on ...
$1,345.00
Read More
Colombia Pharmaceuticals & Healthcare Report

Colombia Pharmaceuticals & Healthcare Report

BMI View: Despite a growing disease burden to address, m ultinational drugmakers will continue to face a tough business environment in Colombia. With a low oil price environment affecting government revenues, authorities will be incentivised ...
$1,345.00
Read More
Costa Rica Pharmaceuticals & Healthcare Report

Costa Rica Pharmaceuticals & Healthcare Report

BMI View: Costa Rica is, and will continue to be , one of the most attractive pharmaceutical market s in the Central America region . Although regulatory and patent enforcement concerns remain, steps are being taken to ...
$1,345.00
Read More
Showing
1-20 of 113